BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8852605)

  • 1. CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells.
    Reinhold D; Wrenger S; Bank U; Bühling F; Hoffmann T; Neubert K; Kraft M; Frank R; Ansorge S
    Immunobiology; 1996 Jan; 195(1):119-28. PubMed ID: 8852605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal X-X-Pro sequence of the HIV-1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen-induced proliferation of human T cells.
    Wrenger S; Reinhold D; Hoffmann T; Kraft M; Frank R; Faust J; Neubert K; Ansorge S
    FEBS Lett; 1996 Apr; 383(3):145-9. PubMed ID: 8925885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells.
    Reinhold D; Bank U; Bühling F; Kähne T; Kunt D; Faust J; Neubert K; Ansorge S
    Immunobiology; 1994 Dec; 192(1-2):121-36. PubMed ID: 7750986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.
    Gutheil WG; Subramanyam M; Flentke GR; Sanford DG; Munoz E; Huber BT; Bachovchin WW
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6594-8. PubMed ID: 7912830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nonapeptides derived from the N-terminal structure of human immunodeficiency virus-1 (HIV-1) Tat on suppression of CD26-dependent T cell growth.
    Wrenger S; Reinhold D; Faust J; Mrestani-Klaus C; Brandt W; Fengler A; Neubert K; Ansorge S
    Adv Exp Med Biol; 2000; 477():161-5. PubMed ID: 10849743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth.
    Wrenger S; Hoffmann T; Faust J; Mrestani-Klaus C; Brandt W; Neubert K; Kraft M; Olek S; Frank R; Ansorge S; Reinhold D
    J Biol Chem; 1997 Nov; 272(48):30283-8. PubMed ID: 9374514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor.
    Wrenger S; Faust J; Mrestani-Klaus C; Fengler A; Stockel-Maschek A; Lorey S; Kahne T; Brandt W; Neubert K; Ansorge S; Reinhold D
    J Biol Chem; 2000 Jul; 275(29):22180-6. PubMed ID: 10896952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function.
    Wrenger S; Faust J; Mrestani-Klaus C; Brandt W; Thielitz A; Neubert K; Reinhold D
    Front Biosci; 2008 May; 13():3194-201. PubMed ID: 18508427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites.
    Lorey S; Stöckel-Maschek A; Faust J; Brandt W; Stiebitz B; Gorrell MD; Kähne T; Mrestani-Klaus C; Wrenger S; Reinhold D; Ansorge S; Neubert K
    Eur J Biochem; 2003 May; 270(10):2147-56. PubMed ID: 12752434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD26/dipeptidyl peptidase IV in lymphocyte growth regulation.
    Ansorge S; Bühling F; Kähne T; Lendeckel U; Reinhold D; Täger M; Wrenger S
    Adv Exp Med Biol; 1997; 421():127-40. PubMed ID: 9330689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of dipeptidyl peptidase IV (DP IV) by anti-DP IV antibodies and non-substrate X-X-Pro- oligopeptides ascertained by capillary electrophoresis.
    Hoffmann T; Reinhold D; Kähne T; Faust J; Neubert K; Frank R; Ansorge S
    J Chromatogr A; 1995 Nov; 716(1-2):355-62. PubMed ID: 8574390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Tat induces cytokine synthesis by uninfected mononuclear cells.
    Rautonen N; Rautonen J; Martin NL; Wara DW
    AIDS; 1994 Oct; 8(10):1504-6. PubMed ID: 7818827
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells.
    Reinhold D; Bank U; Bühling F; Lendeckel U; Faust J; Neubert K; Ansorge S
    Immunology; 1997 Jul; 91(3):354-60. PubMed ID: 9301523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones.
    Reinhold D; Hemmer B; Gran B; Born I; Faust J; Neubert K; McFarland HF; Martin R; Ansorge S
    J Neuroimmunol; 1998 Jul; 87(1-2):203-9. PubMed ID: 9670864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
    Smith RE; Talhouk JW; Brown EE; Edgar SE
    AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus Tat induces functional unresponsiveness in T cells.
    Chirmule N; Than S; Khan SA; Pahwa S
    J Virol; 1995 Jan; 69(1):492-8. PubMed ID: 7983746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production.
    Reinhold D; Bank U; Bühling F; Neubert K; Mattern T; Ulmer AJ; Flad HD; Ansorge S
    Immunobiology; 1993 Aug; 188(4-5):403-14. PubMed ID: 7902330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
    Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness.
    Subramanyam M; Gutheil WG; Bachovchin WW; Huber BT
    J Immunol; 1993 Mar; 150(6):2544-53. PubMed ID: 8095514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26).
    Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
    J Biol Chem; 2005 Apr; 280(15):14911-7. PubMed ID: 15695814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.